MARKET

ESALY

Eisai
ESALY
OTCPK
Delisted
P/E
P/S
P/B
MARKET CAP
54.56
2.851
3.096
17,687,437,155.90
Eli Lilly's Alzheimer's Drug Raises Hopes but Faces Regulatory Hurdles in Europe
Benzinga · 10/14 17:51
Biogen/Eisai's Leqembi Brings Hope To Early Alzheimer's Patients Amid Logistical Challenges
Benzinga · 09/09 14:12
Biogen/Eisai's Alzheimer's Drug Leqembi Gets 'No Go' From European Drug Regulator's Advisory Panel, Cites Serious Side Events
Benzinga · 07/26 14:21
Biogen/Eisai's Popular Alzheimer's Drug Leqembi Is Seeing Slow Adoption - Here's Why
Benzinga · 04/24 18:23
European Medicines Agency Delays Approval Decision For Biogen-Eisai Partnered Alzheimer's Drug Lecanemab
Benzinga · 03/22 17:44
Eli Lilly's Donanemab For Alzheimer's Hits FDA Speed Breaker, Biogen Stock Gains On Delayed Decision
Benzinga · 03/08 13:58
Biogen Could Engage In $1B-$2B Deals To Fill Revenue Shortfall Gaps, Analyst Says
Benzinga · 02/14 20:11
Why Is Biogen Stock Trading Lower On Tuesday?
Benzinga · 02/13 17:42
More

Webull offers Eisai stock information, including OTCPK: ESALY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ESALY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ESALY stock methods without spending real money on the virtual paper trading platform.